Founded in 2009 and based in Des Moines, Washington, GenQual Corporation focuses on developing biomarker diagnostics for disease detection and diagnosis applications. The company's core mission is to enhance early disease detection and improve diagnostic accuracy through innovative biomarker technologies. GenQual offers a range of products, including antibodies, cytokines, and ELISA tests, catering primarily to the medical research and healthcare markets.
Notable affiliated individuals include key researchers and scientists who have contributed to the development of GenQual's diagnostic tools. The company has garnered attention from investors interested in advancing medical diagnostics. Key achievements include the successful development and commercialization of various diagnostic assays that have improved disease detection capabilities. Overall, GenQual has made a significant impact on the field of medical diagnostics, providing essential tools for researchers and healthcare professionals.
